A Phase 1 Trial of CEND-1 in Combination with Nabpaclitaxel and Gemcitabine in Metastatic Exocrine Pancreatic Cancer.

  • Gill, Sanjeev (Primary Chief Investigator (PCI))
  • Cross, Nikki (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date20/09/18 → 20/09/23